TABLE 1.
The demographic and characteristics of the study participants
| Project | COVID‐19 patients | Healthy people | Other diseases patients |
|---|---|---|---|
| Gender | Male 77, female 43 | Male 14, female 21 | Male 25, female 28 |
| Age | 8‐78 | 778 | 28‐96 |
| IgM | 0.20‐115.59 | / | / |
| IgG | 1.39‐297.97 | / | / |
| IL‐10 | 0.01‐115.62 | 0.01‐2.52 | 0.37‐8.87 |
| IL‐1β | 0.02‐18.64 | 0.02‐3.29 | 0.02‐36.95 |
| IL‐6 | 0.03‐305.97 | 0.03‐1.33 | 0.03‐195.71 |
| MCP‐1 | 0.03‐1334.00 | 0.03‐73.18 | 0.03‐255.97 |
| TNF‐α | 0.02‐142.71 | 0.02‐40.69 | 0.02‐99.72 |
| IP‐10 | 0.01‐1267.20 | 12.61‐258.84 | 10.70‐650.32 |
| IL‐4 | 0.01‐240.72 | 0.03‐0.07 | 0.00‐3.63 |